ASCO GU Conference Coverage
Featured Articles
(Triangle Business Journal) Feb 21, 2017 - After announcing disappointing Phase 2 bladder cancer treatment results in November, Durham’s Heat Biologics presented data from its trial at the Genitourinary Cancers Symposium in Orlando last week, along with company outlook in the space.
Read Article
(Genentech) Feb 17, 2017 - Genentech, a member of the Roche Group, today announced encouraging results from the Phase II IMmotion150 study that compared TECENTRIQ® (atezolizumab) plus Avastin® (bevacizumab) and TECENTRIQ monotherapy to sunitinib alone in people with previously untreated, locally advanced or metastatic renal cell...
Read Article
Latest Articles
February 21, 2017
February 21, 2017
February 21, 2017
February 21, 2017
February 17, 2017
February 17, 2017
February 16, 2017
February 14, 2017
View More
News Commentary
There is no ASCO GU Conference Coverage commentary.

OBR Green
There are no ASCO GU Conference Coverage OBR Green articles.
OBR Blog
The 2017 Genitourinary Cancers Symposium takes place in Orlando, FL, on February 16 – 18, and a press cast held in... Read more
February 13, 2017